Edesa Biotech Inc. announced the appointment of Jennifer M. Chao to the company's Board of Directors. Ms. Chao has more than 25 years of experience in the biotech and life sciences industries focused primarily on finance and corporate strategy. She is the founder of CoreStrategies Management, LLC.

Ms. Chao currently serves as a Board Director of Endo International plc. and is a member of its Audit Committee and Compliance Committee. Prior to joining Endo, Ms. Chao served as a Director (since 2015) and as Board Chair (since October 2019) of BioSpecifics Technologies Corp.

until its acquisition by Endo. In addition, since March 2022, she has been a board member of Cardiol Therapeutics Inc. and serves as Chair of Cardiol's Corporate Governance and Compensation Committee.